Colorectal Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jun 1, 2004; 10(11): 1569-1573
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1569
Table 1 Clinicopathological parameters of 45 patients with colorectal carcinoma
Clinicopathological parametersNumbers (%)
GenderMale24 (53.3)
Female21 (46.7)
Age (yr)Range35-81
Mean61.7
Median66.0
Primary siteColon25 (55.6)
Rectum20 (44.4)
I1 (0.22)
II24 (53.3)
III14 (31.1)
IV6 (13.3)
Depth of invasion and Lymph node involvementT1-T2 N07 (15.6)
T3-T4 N018 (40.0)
T1-T2 N1-2N212 (26.7)
T3-T4 N1-N28 (17.8)
Distant MetastasisM039 (86.7)
M16 (13.3)
Histological gradeG112 (26.7)
G222 (48.9)
G311 (24.4)
Tumor size> 5 cm22 (48.9)
≤ 5 cm23 (51.1)
Table 2 Expressions of p-Stat3, cyclin D1, and Bcl-xL in colorectal carcinoma (mean ± SD)
ItemsnPercentage (%)A Value
tP
TumorNormal
p-Stat34557.8 (26/45)114263 ± 5359855971 ± 287623.5730.002
cyclin D14564.4 (29/45)58321 ± 2487222563 ± 111605.1910.0001
Bcl-xL4568.9 (31/45)71032 ± 4342537281 ± 146224.6270.0001
Table 3 Correlations between p-Stat3, cyclin D1, Bcl-xL and clinicopathological parameters in colorectal carcinoma (mean ± SD)
Itemnp-Stat3Pcyclin D1PBcl-xLP
Gender
Male242.7 ± 0.60.8464.1 ± 1.60.9133.7 ± 1.20.746
Female212.5 ± 0.54.3 ± 1.83.3 ± 1.1
Age (yr)
≥ 65222.8 ± 0.70.7364.8 ± 2.10.8253.4 ± 1.50.870
< 65232.4 ± 0.43.6 ± 1.33.6 ± 0.8
Stage
III + IV203.6 ± 0.60.0265.2 ± 1.90.0654.2 ± 1.30.235
I + II251.8 ± 0.53.4 ± 1.53.1 ± 1.0
Histological
Grade
G1122.3 ± 0.50.7784.7 ± 1.80.7323.9 ± 1.30.894
G2222.4 ± 0.60.6454.2 ± 1.40.6273.3 ± 1.00.771
G3113.4 ± 0.60.5303.6 ± 2.20.5653.6 ± 1.20.832
Node
Metastasis
Positive273.8 ± 0.80.0185.5 ± 1.90.0414.4 ± 1.40.162
Negative181.6 ± 0.43.3 ± 1.52.9 ± 1.0
Distant
Metastasis
M163.6 ± 0.80.6385.4 ± 2.20.6125.2 ± 1.60.324
M0392.5 ± 0.54.0 ± 1.63.3 ± 1.1
Tumor Size
≥ 5 cm223.0 ± 0.70.5824.5 ± 1.80.7763.8 ± 1.30.735
< 5 cm232.2 ± 0.43.9 ± 1.63.2 ± 1.0